FDA Import Refusal 799-8813461-2/11/1 — GLAXO SMITHKLINE PHARMACEUTICALS
The FDA refused shipment 799-8813461-2/11/1 from GLAXO SMITHKLINE PHARMACEUTICALS (India) on Dec 3, 2018. The refused product falls under Drugs and Biologics — LEVOTHYROXINE SODIUM (THYROID HORMONE). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Dec 3, 2018
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66JCA01 LEVOTHYROXINE SODIUM (THYROID HORMONE)
- Charges
- 75